| Marie B Richards, MSSW, LCSW | |
|
1547 Strongs Ave Ste D, Stevens Point, WI 54481-3566 | |
| (715) 303-2900 | |
| (715) 303-2928 |
| Full Name | Marie B Richards |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 24 Years |
| Location | 1547 Strongs Ave Ste D, Stevens Point, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669594107 | NPI | - | NPPES |
| 40993500 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6997123 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Point Counseling Center Llc | 2264865971 | 6 |
News Archive
Caffeine is the most available and widely used psychoactive substance in the world and is the only drug legally accessible and socially acceptable for consumption by children and adolescents. Some studies have shown that adolescents are the fastest-growing population of caffeine users, with 83.2% consuming caffeinated beverages regularly and at least 96% consuming them occasionally.
With the onset of COVID-19, the focus of medical research has been on tracing the origin of SARS-CoV-2, which was first reported in China's Wuhan city.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
In September, patients suffering from multiple sclerosis (MS) received the welcome news that the U.S. Food and Drug Administration (FDA) had approved a promising new drug for their condition called Gilenya. Now, a team from The Scripps Research Institute has discovered that this drug's success may involve an unexpected biological mechanism acting within the central nervous system (CNS). This difference may mean that Gilenya offers even more benefits than previously realized and would represent the first MS therapy with direct CNS activities.
› Verified 5 days ago
| Entity Name | Point Counseling Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871138115 PECOS PAC ID: 2264865971 Enrollment ID: O20191211002097 |
News Archive
Caffeine is the most available and widely used psychoactive substance in the world and is the only drug legally accessible and socially acceptable for consumption by children and adolescents. Some studies have shown that adolescents are the fastest-growing population of caffeine users, with 83.2% consuming caffeinated beverages regularly and at least 96% consuming them occasionally.
With the onset of COVID-19, the focus of medical research has been on tracing the origin of SARS-CoV-2, which was first reported in China's Wuhan city.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
In September, patients suffering from multiple sclerosis (MS) received the welcome news that the U.S. Food and Drug Administration (FDA) had approved a promising new drug for their condition called Gilenya. Now, a team from The Scripps Research Institute has discovered that this drug's success may involve an unexpected biological mechanism acting within the central nervous system (CNS). This difference may mean that Gilenya offers even more benefits than previously realized and would represent the first MS therapy with direct CNS activities.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marie B Richards, MSSW, LCSW 4280 Windsong Pl, Plover, WI 54467-9018 Ph: (608) 698-9452 | Marie B Richards, MSSW, LCSW 1547 Strongs Ave Ste D, Stevens Point, WI 54481-3566 Ph: (715) 303-2900 |
News Archive
Caffeine is the most available and widely used psychoactive substance in the world and is the only drug legally accessible and socially acceptable for consumption by children and adolescents. Some studies have shown that adolescents are the fastest-growing population of caffeine users, with 83.2% consuming caffeinated beverages regularly and at least 96% consuming them occasionally.
With the onset of COVID-19, the focus of medical research has been on tracing the origin of SARS-CoV-2, which was first reported in China's Wuhan city.
A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.
In September, patients suffering from multiple sclerosis (MS) received the welcome news that the U.S. Food and Drug Administration (FDA) had approved a promising new drug for their condition called Gilenya. Now, a team from The Scripps Research Institute has discovered that this drug's success may involve an unexpected biological mechanism acting within the central nervous system (CNS). This difference may mean that Gilenya offers even more benefits than previously realized and would represent the first MS therapy with direct CNS activities.
› Verified 5 days ago
Mrs. Michelle Ann Nelson, MSW LCSW CADC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 209 Prentice St N, Stevens Point, WI 54481 Phone: 715-344-4611 | |
Mr. Stacey L. Salyers, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1466 Water St, Suite 2, Stevens Point, WI 54481 Phone: 715-341-6672 Fax: 715-341-8004 | |
Natalie Wachowiak, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 497 W Mapleridge Dr, Stevens Point, WI 54481 Phone: 847-345-9326 | |
Steven Bruce Pray, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 817 Whiting Ave, Stevens Point, WI 54481 Phone: 715-345-5350 Fax: 715-345-5966 | |
Debra L Spranger, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3398 East Maria Drive, Stevens Point, WI 54481 Phone: 715-341-7441 | |
Laura Adams-burkley, LCSW, CADC Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 209 Prentice St North, Box 8004, Stevens Point, WI 54481 Phone: 715-344-4611 Fax: 715-344-8127 | |
Nancy Jane Schaperkotter, AM,MSW,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1052 Main St, Suite 202, Stevens Point, WI 54481 Phone: 715-343-5256 Fax: 715-343-5899 |